Literature DB >> 7553088

Histological, immunohistochemical, and ultrastructural findings in human corneas after photorefractive keratectomy.

E Balestrazzi1, V De Molfetta, L Spadea, P Vinciguerra, G Palmieri, G Santeusanio, L Spagnoli.   

Abstract

BACKGROUND: Four human corneas that had undergone photorefractive keratectomy (PRK) and subsequent penetrating keratoplasty were examined by means of light and electron microscopy in an attempt to detect possible causes for complications after PRK.
METHODS: Four eyes with a central corneal leukoma resulting from a previous PRK treatment underwent penetrating keratoplasty respectively 3 days, 3 months, 5 months, and 13 months after the refractive procedure. Different excimer laser instruments (Meditec MEL 50, Summit UV200, and VISX 20/20) had been used. The corneal buttons removed were submitted for light microscopy, electron microscopy and immunohistochemistry.
RESULTS: An immature (one to two layers, basement membrane anomalies) but continuous epithelium was present even in the 3-day specimen; between six and eight epithelial layers could be seen in the 13-month specimen, which still presented an undulated aspect of the otherwise normal basement membrane. A continuous acellular collagen layer underlying the epithelium of the ablated area was detected in the superficial stroma of all examined corneas. No Descemet's membrane or endothelial alterations could be seen.
CONCLUSIONS: Despite recovery of a continuous epithelial layer as early as 3 days after PRK, abnormalities of both epithelium and superficial stroma could be detected in all specimens, including the one obtained 13 months after the refractive procedure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553088

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  9 in total

1.  Corneal wound healing after photorefractive keratectomy: a 3-year confocal microscopy study.

Authors:  Jay C Erie
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  Keratocyte density in vivo after photorefractive keratectomy in humans.

Authors:  J C Erie; S V Patel; J W McLaren; L J Maguire; M Ramirez; W M Bourne
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Keratocyte density in the retroablation area after LASEK for the correction of myopia.

Authors:  Wolfgang Artur Herrmann; Manuela Muecke; Michael Koller; Veit Peter Gabel; Chris Patrick Lohmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-06-01       Impact factor: 3.117

4.  Intact corneal epithelium is essential for the prevention of stromal haze after laser assisted in situ keratomileusis.

Authors:  K Nakamura; D Kurosaka; H Bissen-Miyajima; K Tsubota
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

5.  Histological changes and wound healing response following noncontact holmium: YAG laser thermal keratoplasty.

Authors:  D D Koch
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  Long term results of no-alcohol laser epithelial keratomileusis and photorefractive keratectomy for myopia.

Authors:  Leopoldo Spadea; Francesca Verboschi; Vittoria De Rosa; Mariella Salomone; Enzo Maria Vingolo
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

7.  Effectiveness of scraping and mitomycin C to treat haze after myopic photorefractive keratectomy.

Authors:  Leopoldo Spadea; Valerio Verrecchia
Journal:  Open Ophthalmol J       Date:  2011-12-30

8.  Clinical Outcomes of an Optimized Prolate Ablation Procedure for Correcting Residual Refractive Errors Following Laser Surgery.

Authors:  Byunghoon Chung; Hun Lee; Bong Joon Choi; Kyung Ryul Seo; Eung Kwon Kim; Dae Yune Kim; Tae-Im Kim
Journal:  Korean J Ophthalmol       Date:  2017-02-02

9.  Comparison of refractive outcomes after photorefractive keratectomy with different optical zones using Mel 90 excimer laser.

Authors:  Dae Hwan Shin; Yong Woo Lee; Ji Eun Song; Chul Young Choi
Journal:  BMC Ophthalmol       Date:  2020-07-09       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.